1 |
EANcore COVID-19 on EANpages |
text |
2 |
Apply now |
text |
3 |
EAN pages |
text |
4 |
Virtual Congress |
text |
5 |
My EAN |
text |
6 |
EANcore COVID-19 on EANpages |
text |
7 |
The Brain Prize |
text |
8 |
Calendar |
text |
9 |
Apply now |
text |
10 |
Watch the Opening Session! |
text |
11 |
EAN pages: Latest posts |
text |
12 |
EAN Virtual Congress breaks records with more than 42,500 partic****nts |
text |
13 |
EAN Virtual Congress -Symposium 8: Non-Alzheimer pathology in the elderly: what to do? |
text |
14 |
EAN VIRTUAL CONGRESS – EAN/ESO: Update on acute stroke treatment |
text |
15 |
EAN VIRTUAL CONGRESS -Resident and Research Fellow Section General a***embly |
text |
16 |
EAN Virtual Congress: Symposium 6: Highlights in the expanding arena of autonomic disorders |
text |
17 |
Symposium 3: EAN/IFCN-EMEAC: Neurophysiology and non- invasive brain stimulation (NIBS) |
text |
18 |
NEuro-covid ReGistrY (ENERGY) |
text |
19 |
COVID-19 presenting with ophthalmoparesis from cranial nerve palsy |
text |
20 |
Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection |
text |
21 |
Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection |
text |
22 |
Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System a***ociation (ASNP) |
text |
23 |
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network |
text |
24 |
Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas |
text |
25 |
Recommendations for Deep Brain Stimulation Device Management During a Pandemic |
text |
26 |
COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care |
text |
27 |
An Italian programme for COVID-19 infection in multiple sclerosis |
text |
28 |
COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach |
text |
29 |
a***ociation of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State |
text |
30 |
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial |
text |
31 |
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 |
text |
32 |
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia |
text |
33 |
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study |
text |
34 |
Interpreting Diagnostic Tests for SARS-CoV-2 |
text |
35 |
Reports |
text |
36 |
COVID-19 – RRFS REPRESENTATIVE REPORT: Austria |
text |
37 |
Scientific Programme |
text |
38 |
6th EAN Congress |
text |
39 |
Cancelled - 6th International Dystonia Symposium |
text |
40 |
The European Human Genetics Conference 2020.2 |
text |
41 |
Cancelled - 3rd European Congress on Post-Polio Syndrome |
text |
42 |
EAN Spring School - Postponed |
text |
43 |
Tweets by EANeurology |
text |
44 |
European Academy of Neurology |
text |
45 |
Sieh dir diesen Beitrag auf Instagram an |
text |
46 |
Ein Beitrag geteilt von European Academy of Neurology (@eaneurology) |
text |
47 |
- |
empty |
48 |
- |
empty |
49 |
EANcore COVID-19 on EANpages |
text |
50 |
Apply now |
text |